Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
Abbott TriClip device for TEER

EuroPCR 2023: Late-breaking research examines the latest in TEER, TAVR and PCI outcomes

Catch up on key late-breaking research from Abbott, Edwards Lifesciences and Philips presented at the four-day meeting in Paris. 

Innovation in the cath lab: Cardiologists develop, perform new interventional heart procedure

Interventional cardiologists in Detroit developed the new technique with a specific patient in mind. One specialist described it as an "exciting breakthrough."

Mitral Valve Surgery from the University of Washington

Cardiologists make history, removing device and implanting new valve in first heart procedure of its kind

“I was ready to make out my will, so this came along just at the right time,” the 76-year-old patient said. 

A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare

TVT 2023: Cardiovascular Research Foundation announces late-breaking clinical trials

In addition to these 15 late-breaking clinical studies, TVT 2023 will feature live cases, hands-on training, poster presentations and much more.

Data on a next-generation balloon-expandable transcatheter heart valve

Next-gen TAVR valve, tested on patients for very first time, linked to high success rate

A new-look TAVR valve was tested on patients for the first time, leading researchers to say its use appears to be "feasible and safe." More research, of course, is still required. 

A TAVR procedure being performed at Northwestern Medicine in Chicago. These structural heart procedures require a team approach.

Is TAVR too common among younger, low-risk patients? 2 experts share their concerns

Two experienced TAVR specialists—Sachin Goel, MD, and Michael Reardon, MD—examined the growing trend of younger, low-risk patients being recommended for TAVR over SAVR.

X-ray photon trajectory during the simulation phantom study from the side and top views. Due to scattering of the X-rays when they hit the lower end of the patient bed, exposure in mainly to the lower body of the interventional echocardiographer performing transesophageal echocardiography. The green lines are the scattered photon trajectories calculated by Monte Carlo simulation in the study.

Radiation exposure in the cath lab: Tracking the impact on interventional echocardiographers

Researchers found that echocardiographers in the cath lab are exposed to high doses of radiation on the right half of their body, especially the waist and lower body. 

New ASE guideline outlines training standards for interventional echocardiography

The American Society of Echocardiography (ASE) released a new guideline document that outlines uniform training standards for interventional sonographers guiding structural heart procedures.

Displaying 297 - 304 of 876
Design by Adaptive Theme